PEAK6 Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$240K Sell
8,300
-368,000
-98% -$10.7M ﹤0.01% 2690
2024
Q2
$10.5M Buy
376,300
+314,100
+505% +$8.65M 0.03% 471
2024
Q1
$1.73M Sell
62,200
-78,200
-56% -$2.17M ﹤0.01% 1554
2023
Q4
$4.04M Buy
140,400
+67,900
+94% +$2.05M 0.02% 998
2023
Q3
$2.4M Sell
72,500
-34,400
-32% -$1.22M 0.01% 1214
2023
Q2
$3.92M Buy
106,900
+46,500
+77% +$1.81M 0.02% 780
2023
Q1
$2.46M Sell
60,400
-67,600
-53% -$2.92M 0.01% 1129
2022
Q4
$6.56M Sell
128,000
-40,500
-24% -$1.94M 0.04% 560
2022
Q3
$7.37M Sell
168,500
-199,700
-54% -$9.7M 0.03% 593
2022
Q2
$17.6M Buy
368,200
+65,600
+22% +$3.34M 0.03% 521
2022
Q1
$15.7M Sell
302,600
-661,500
-69% -$34.3M 0.03% 504
2021
Q4
$56.9M Buy
964,100
+192,800
+25% +$9.55M 0.12% 156
2021
Q3
$33.2M Buy
771,300
+527,292
+216% +$23.4M 0.07% 229
2021
Q2
$15.1M Sell
244,008
-163,992
-40% -$6.38M 0.04% 487
2021
Q1
$14.8M Sell
408,000
-18,839
-4% -$669K 0.04% 459
2020
Q4
$15.7M Sell
426,839
-324,874
-43% -$11.9M 0.03% 478
2020
Q3
$26.2M Buy
751,713
+128,377
+21% +$4.5M 0.06% 267
2020
Q2
$19.3M Buy
623,336
+47,536
+8% +$1.61M 0.07% 269
2020
Q1
$17.8M Buy
575,800
+488,634
+561% +$16.6M 0.1% 181
2019
Q4
$3.24M Buy
87,166
+47,009
+117% +$1.67M 0.02% 835
2019
Q3
$1.37M Sell
40,157
-7,484
-16% -$272K 0.01% 1532
2019
Q2
$1.96M Sell
47,641
-46,903
-50% -$1.86M 0.01% 1307
2019
Q1
$3.81M Buy
94,544
+73,991
+360% +$2.96M 0.02% 873
2018
Q4
$851K Sell
20,553
-52,700
-72% -$2.19M 0.01% 1896
2018
Q3
$3.06M Buy
+73,253
New +$2.82M 0.01% 1116

Other funds holding PFE

PEAK6 Investments's PFE Position: Q3 2024 in Review

PEAK6 Investments sold out of Pfizer (PFE) in Q3 2024, closing a stake of 27,903 shares — an estimated $814K sold.

PEAK6 Investments first reported a position in PFE in Q1 2019 and held it in 19 quarters. The position peaked at $9.74M in Q1 2020. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • PEAK6 Investments reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 27,903 Pfizer shares in Q3 2024, an estimated $814K.
  • PEAK6 Investments first reported a position in Pfizer in Q1 2019 and held it in 19 quarters.
  • PEAK6 Investments's Pfizer position peaked at $9.74M in Q1 2020.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.